Fact CheckerSign in

NCT07002125Recruiting

Whole Body Vibration Therapy in Individuals With Type 2 Diabetes

The Effect of Whole Body Vibration Therapy on Muscle Oxygenation in Individuals With Type 2 Diabetes: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 26 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The aim of this interventional study is to investigate the effect of whole body vibration therapy on muscle oxygenation, vibration sensation, functional capacity and balance in individuals with Type 2 diabetes. The main questions aimed to be answered are: * Does whole body vibration therapy affect peripheral muscle oxygenation? * Does whole body vibration therapy improve vibration sense, functional capacity and balance compared to aerobic exercise? Participants' muscle oxygenation, vibration sensation, functional capacity and balance parameters will be assessed. They will participate in a whole body vibration therapy or aerobic training program.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
17 May 2025
Start date
1 Aug 2025
Primary completion date
1 Dec 2025
Lead sponsor
Ankara Medipol University
NCT number
NCT07002125

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 1 Aug 2025 to the primary completion date, 1 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous or concurrent psychiatric, neurological, orthopedic or systemic illness

Other illness

  • Foot ulcer
  • History of major hypoglycemia in the last 12 months
  • Conditions that may contraindicate whole body vibration (deep vein thrombosis, severe osteoporosis, active cancer, implanted medical devices, etc.)

Other

  • Use of insulin in treatment
  • Diabetic neuropathy
  • Participation in any exercise program in the last 6 months
  • Working or have worked in a job with high exposure to mechanical whole body vibrations
  • Hearing, vision and perception problems that may affect research results

Who the study is looking for

  • Volunteering to participate in the research
  • Being diagnosed with type 2 diabetes
  • 18 years of age or older
  • HbA1c level to be 6.5-10%
  • Having a clinical history of diabetes between 2-10 years
  • Receiving oral hypoglycemic agent treatment
  • At least three HbA1c measurements within 12 to 24 months
  • Hemoglobin variability score (HVS) \<50
  • Being able to walk independently
  • Mini mental test score ≥ 24
  • Vastus lateralis muscle adipose tissue thickness \<20mm
  • BMI \<30 kg/m2

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gazi University, Faculty of Health, Department of Physiotherapy and Rehabilitation
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.